Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index; 9 of the 38 sources its claims cite were checked for support.

Pre-, Pro-, Post- and Synbiotics in Pediatric Short Bowel Syndrome: A Narrative Review of Current Evidence

Open access

Abstract

BACKGROUND: Pediatric Short bowel syndrome (SBS) is the leading cause of intestinal failure and is characterized by persistent dysbiosis that negatively impacts intestinal adaptation and growth. Although microbiota modulation via pre-, pro-, and synbiotics represents a promising strategy, current evidence remains fragmented. This narrative review aims to critically assess the efficacy and safety of such interventions in the management of pediatric SBS. METHODS: A structured literature search was conducted on PubMed up to November 2025. Fourteen relevant studies were included, comprising clinical trials, preclinical animal models, and significant case reports regarding the use of biotics in SBS. RESULTS: The analysis reveals a microbiological dichotomy based on nutritional status: parenteral nutrition (PN)-dependent patients exhibit an excess of Proteobacteria associated with infectious risk, whereas weaned patients present a metabolic risk of D-lactic acidosis due to carbohydrate fermentation. Regarding efficacy, long-term synbiotic treatments (>12 months) demonstrated significant improvements in growth and nutritional status, likely mediated by increased production of short-chain fatty acids (SCFAs) and mucosal adaptation, unlike short-term probiotic cycles. However, serious adverse events (Lactobacillus sepsis and D-lactic acidosis) were reported, predominantly in patients with central venous catheters or malabsorption. CONCLUSIONS: Biotics offer therapeutic potential for intestinal failure, but their use cannot be empirical. The safety profile should be carefully selected, especially in central venous catheter (CVC) carriers. Future strategies must evolve towards precision medicine, prioritizing non-D-lactate-producing strains and personalized protocols based on the patient's nutritional phase.

Overview

CoChat Summary

TL;DR

This narrative review concludes that pre-, pro-, and synbiotics have theoretical and some observed benefits in pediatric short bowel syndrome, but clinical translation is constrained by very limited and heterogeneous evidence. Safety is a major concern: in about 50 pediatric patients across included studies and case reports, 4 serious adverse events (8%) were reported, mainly Lactobacillus bacteremia in catheter-dependent patients.

Key findings

  • The review included 14 articles: 4 clinical studies, 4 preclinical/translational animal studies, and 6 case reports.
  • In the cumulative analysis of approximately 50 pediatric patients, 4 serious adverse events (8%) were recorded; 3 of the 4 were Lactobacillus bacteremia, and the paper says these occurred in PN-dependent, CVC-carrying patients.
  • Short-term probiotic trials were not clearly beneficial: a 4-week LGG study in 9 children with SBS found no significant improvement in intestinal permeability or stable colonization, and a 2-month trial in 18 weaned, suboptimally growing children found no significant differences in microbiota composition or anthropometric outcomes versus placebo.
  • Long-term synbiotic therapy (>12 months) was associated with better outcomes: in one cohort of 7 children, 6/7 had accelerated weight gain and 5/7 improved rapid-turnover proteins; another small cohort showed increased fecal SCFAs and improved immunonutritional parameters.

Methods

  • Narrative review with a structured PubMed search covering studies published from 2001 to November 2025; gray literature was excluded.
  • Eligibility focused on pediatric postsurgical SBS (neonates, children, adolescents up to 18 years) and microbiota-targeted interventions; the initial search retrieved 32 articles, and 14 were included after screening.
  • The review qualitatively synthesized clinical studies, animal studies, and case reports, with outcomes centered on safety (adverse events) and efficacy (symptom trends before/after treatment).

Limitations

  • The paper states that evidence is scarce, heterogeneous, and largely non-randomized; it notes the lack of large-scale, multicenter randomized controlled trials limits statistical power and generalizability.
  • The authors state that concurrent antibiotic use is a confounder that can independently alter dysbiosis or mask treatment effects.
  • Evident from the text: the review’s included studies vary widely in design, strain, dose, duration, and delivery route, and the evidence base includes only small cohorts and case reports, which makes firm conclusions difficult.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/children13030349

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 PRISMA flow diagram.
Figure 1 PRISMA flow diagram.CC BY · PubMed Central

Verification

Claims the paper makes

6 Valid · 0 Not valid · 23 Not checked · 25 Own results and interpretations

14 more claims

Create a free account to see all 54 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 32
  • Probably not a substantial claim. 3
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 34 references

Cited by

See all 3

Metadata

Authors
Ruiz, R. G., Morelli, A., Grieco, R., Cardile, S., Capriati, T., Trovato, C. M., Bolasco, G., Knafelz, D., Bracci, F., Alterio, A., & Diamanti, A.
Affiliations
  • Università Cattolica del Sacro Cuore (IT)
  • University of Salerno (IT)
  • Bambino Gesù Children's Hospital (IT)
Corresponding author
Morelli, Annalisa
Venue
Children
Publisher
MDPI AG
Published
2026-02-28
Volume
13
Issue
3
Pages
349
ISSN
2227-9067 (ISSN-L)
OpenAlex
W7132827108
Cited by
3
References
34
Citations by year
2026: 3
FWCI
3.46
Type
journal article
Language
en
Open access
Locations
  • Children (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Italian Ministry of Health with “Current Research funds”
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Health Sciences › Nursing › Nutrition and Dietetics › Infant Nutrition and Health
Keywords
intestinal failure, prebiotics, probiotics, synbiotics, gut dysbiosis, gut microbiota, D-lactic acidosis, short-chain fatty acids, mucosal adaptation, parenteral nutrition, central venous catheters, precision medicine, nutritional status

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pre-, Pro-, Post- and Synbiotics in Pediatric Short Bowel Syndrome: A Narrative Review of Current Evidence. https://app.cochat.ai/papers/10.3390/children13030349
The paper
Ruiz, R. G., Morelli, A., Grieco, R., Cardile, S., Capriati, T., Trovato, C. M., Bolasco, G., Knafelz, D., Bracci, F., Alterio, A., & Diamanti, A. (2026). Pre-, Pro-, Post- and Synbiotics in Pediatric Short Bowel Syndrome: A Narrative Review of Current Evidence. Children. https://doi.org/10.3390/children13030349

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.